[1] 葛海龙, 马晓海, 赵蕾,等. 老龄冠状动脉粥样硬化性心脏病患者冠状动脉钙化危险因素分析[J].心肺血管病杂志, 2016, 35(7):258-260.
[2] 金勇, 陈夏欢, 陈亚红,等. 老年冠状动脉粥样硬化性心脏病患者冠状动脉病变程度与无创中心动脉压的相关性研究[J].中国医药, 2016, 11(3):12-14.
[3] Bonafini S, Antoniazzi F, Maffeis C,et al. Beneficial effects of ω-3 PUFA in children on cardiovascular risk factors during childhood and adolescence[J].Prostaglandins Other Lipid Mediat,2015,120: 72-79.
[4] 郑杨剑, 王文娜. Omega-3多价不饱和脂肪酸与冠心病[J].心脑血管病防治,2016. 16(3): 224-225,231.
[5] 吴艳君, 王俊. 白介素-6与心力衰竭患者心肌重构的关系研究[J].中华全科医学, 2014, 12(3):378-379.
[6] Dumic J, Dabelic S, Flgel M. Galectin-3: an open-ended story[J].Biochim Biophys Acta,2006,1760(4): 616-635.
[7] 张泉水, 罗文鸿, 李慧, 等. 人静脉血浆中四种不饱和脂肪酸的气相色谱分析[J].色谱,2003,21(5): 530.
[8] Libby P, Ridker PM , Maseri A. Inflammation and atherosclerosis [J].Circulation,2002,105: 11351143.
[9] Jian-Fen H, Chen H, Cardiology DO, et al. To exammination the correlation of acute coronary syndromes patients and their Hcy,IL-6,BNP,D-dimer level[J].J Clin Exp Med,2016,22(9): 37-42.
[10] Yaseen F, Jaleel A, Aftab J, et al. Circulating levels of resistin, IL-6 and lipid profile in elderly patients with ischemic heart disease with and without diabetes[J].Biomarkers Med,2015, 6(1):97-102.
[11] Jain AP,Aggarwal KK, Zhang PY. Omega-3 fatty acids and cardiovascular disease[J].Eur Rev Med Pharmacol Sci,2015, 19(3): 441-445.
[12] Mozaffarian D, Lemaitre RN, King IB,et al. Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study [J].Ann Intern Med,2013,158(7):515-525.
|
2017, Vol. 34 
